PlainPharmaWatch

CMS Open Payments · Tool

Elucid Bioimaging Inc vs Geron Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Elucid Bioimaging Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 8,681, versus 985 for the other company. Its single largest recorded recipient represents 0.9% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Elucid Bioimaging Inc
HHI 8,681 · top recipient 0.9%
Ranked #183 of 1,838 companies by HHI
Geron Corporation
HHI 985 · top recipient 0.2%
Ranked #1,036 of 1,838 companies by HHI

Payment Overview

Total Payments
$130.1K
% of Industry
0.0%
Transactions
6
Avg per Transaction
$21.7K
Recipients
6
Avg per Recipient
$21.7K
Payment Types
1
Top Payment Type
Consulting Fee
Company B

Geron Corporation

Total Payments
$129.2K
% of Industry
0.0%
Transactions
617
Avg per Transaction
$209.42
Recipients
442
Avg per Recipient
$292.33
Payment Types
4
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Elucid Bioimaging Inc vs Geron Corporation - total reported payments in CMS Open Payments PY2024

Elucid Bioimaging Inc$130.1KGeron Corporation$129.2K

Payment Types Breakdown

Elucid Bioimaging Inc

Consulting Fee $130.1K

100.0%

Geron Corporation

Compensation for Services Other Than Consulting $59.5K

46.1%

Consulting Fee $16.1K

12.5%

Food and Beverage $11.3K

8.7%

Travel and Lodging $4.3K

3.3%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Elucid Bioimaging Inc

  1. 1

    AMIR AHMADI

    $121,040.00 · 1 txns

  2. 2

    MARK RABBAT

    $5,212.50 · 2 txns

  3. 3

    RICHARD THOMAS

    $2,613.50 · 2 txns

  4. 4

    MATTHEW BUDOFF

    $1,200.00 · 1 txns

Geron Corporation

  1. 1

    ROBERT JAY SPIEGEL

    $17,738.60 · 4 txns

  2. 2

    ESTHER HELEN ROSE

    $13,825.00 · 1 txns

  3. 3

    SURESH KUMAR BALASUBRAMANIAN

    $8,990.00 · 3 txns

  4. 4

    AHMED ZAKARI

    $8,313.30 · 7 txns

  5. 5

    JAMES MCCLOSKEY

    $8,016.76 · 4 txns

Summary Comparison

Metric Elucid Bioimaging Inc Geron Corporation
Total Payments $130.1K $129.2K
% of Industry Total 0.0% 0.0%
Transaction Count 6 617
Avg per Transaction $21.7K $209.42
Recipient Count 6 442
Avg per Recipient $21.7K $292.33
Payment Type Count 1 4
Top Payment Type Consulting Fee Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.